Archives of Toxicology

, Volume 59, Issue 1, pp 4–6 | Cite as

Studies on the genotoxicity of the anabolic drugs trenbolone and zeranol

  • M. Scheutwinkel
  • W. v. d. Hude
  • A. Basler
Original Investigations


The androgen trenbolone, and the mycoestrogen zeranol, both anabolic drugs, were tested for their genotoxic potential. Test systems were the SOS-chromotest, the rec-assay and the V79 sister chromatid exchange test without and with metabolic activation using rat liver homogenates and primary rat hepatocytes.

It is still a matter of debate if trenbolone has carcinogenic properties, because of its cell transforming activity in vitro. Trenbolone, however, did not demonstrate any genotoxic effect in the assays performed. The results obtained for zeranol were also negative in the SOS-chromotest and V79 sister chromatid exchange test but positive in the rec-assay.

Key words

Genotoxicity Zeranol Trenbolone Anabolic drugs 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ames BN, McCann J, Yamasaki E (1975) Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 31: 347–364Google Scholar
  2. Banduhn N, Obe G (1985) Mutagenicity of 2-benzimidazolecarbamate, diethylstilbestrol and estradiol: Structural chromosomal aberrations, sister-chromatid exchanges, C-mitosis, polyploididies and micronuclei, Mutat Res 156: 199–218Google Scholar
  3. Barrett JC, Wong A, McLachlan JA (1981) Diethylstilbestrol induces neoplastic transformation without measurable gene mutation at two loci. Science 212: 1402–1404Google Scholar
  4. Barrett JC, McLachlan JA, Elmore E (1983) Inability of diethylstilbestrol to induce 6-thioguanine resistant mutants and to inhibit metabolic cooperation of V79 Chinese Hamster cells Mutat Res 107: 427–432Google Scholar
  5. Basler A, v. d. Hude W, Scheutwinkel-Reich M (1985) Formaldehyde-induced sister chromatid exchanges in vitro and the influence of the exogenous metabolizing systems S9 mix and primary rat hepatocytes. Arch Toxicol 58: 10–13Google Scholar
  6. Glatt HR, Metzler M, Oesch F (1979) Diethylstilbestrol and 11 derivatives, a mutagenicity study with Salmonella typhimurium. Mutat Res 67: 113–121Google Scholar
  7. Heitzmann RJ (1979) The efficacy and mechanism of action of anabolic agents as growth promotors in farm animals. J Steroid Biochem 11: 927–930Google Scholar
  8. Hill A, Wolff S (1982) Increased induction of sister chromatid exchange by diethylstilbestrol in lymphocytes from pregnant and premenopausal women. Cancer Res 42: 893–896Google Scholar
  9. Ingerowski GH, Scheutwinkel-Reich M, Stan HJ (1981) Mutagenicity studies on veterinary anabolic drugs with the Salmonella/microsome test. Mutat Res 91: 93–98Google Scholar
  10. Kada T, Sadaie Y, Sakamoto Y (1984) Bacillus subtilis repair test. In: Handbook of mutagenicity test procedures, Kilbey BJ, Legator M, Nichols W, Ramel C (eds) Elsevier Science Publishers, Amsterdam, pp 13–30Google Scholar
  11. Langenbach R, Freed HJ, Raveh D, Hubermann E (1978) Cell specificity in metabolic activation of aflatoxin B1 and benzo(a)pyrene to mutagens for mammalian cells. Nature 276: 277–279Google Scholar
  12. Latt SA, Allen J, Bloom SE, Carrano A, Falke E, Kram E, Schneider E, Wolff R, Schreck R, Tice R, Whitfield B (1981) Sister chromatid exchanges: A report of the Gene Tox Program. Mutat Res 87: 17–62Google Scholar
  13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275Google Scholar
  14. Mehnert H, Speit G, Vogel W (1985) Effect of diethylstilbestrol on the frequencies of sister chromatid exchange in vitro and in vivo. Cancer Res 45: 3626–3630Google Scholar
  15. Quillardet P, Huisman O, D'Ari R, Hofnung M (1982) SOS chromotest a direct assay of induction of an SOS function in Escherichia coli to measure genotoxicity. Proc Natl Acad Sci USA 79: 5971–5975Google Scholar
  16. Quillardet P, de Bellecombe C, Hofnung M (1985) The SOS chromotest, a colorimetric bacterial assay for genotoxins: validation study with 83 compounds. Mutat Res 147: 79–95Google Scholar
  17. Rüdiger HW, Haenisch F, Metzler M, Oesch F, Glatt HR (1979) Metabolites of diethylstilbestrol induce sister chromatid exchange in cultured fibroblasts. Nature 281: 392–394Google Scholar
  18. Rumruen K, Pool BL (1984) Metabolic activation capabilities of S9 and hepatocytes from uninduced rats to convert carcinogenic N-nitrosamines to mutagens. Mutat Res 140: 147–153Google Scholar
  19. Scheutwinkel-Reich M, Preiss AM, v. d. Hude W, Stan HJ (1984) In vitro SCE analysis of the veterinary anabolic drugs zeranol and trenbolone. Mutat Res 130: 257Google Scholar
  20. Schiffmann D, Metzler M, Neudecker T, Henschler D (1985) Morphological transformation of Syrian Hamster embryo fibroblasts by the anabolic agent trenbolone. Arch Toxicol 58: 59–63Google Scholar
  21. de Serres FJ, Ashby J (eds) (1981) Evaluation of short-term tests for carcinogens. Report of the international collaborative program, New York, Elsevier/North-Holland Biomedical Press, pp 437, 495, 521, 530, 541, 562, 571, 583, 634, 675Google Scholar
  22. Stan HJ (1979) Anabole Wirkstoffe in der Tiermast: Anwendung und Rückstandsanalytik. Chem Labor Betr 30: 133–138Google Scholar
  23. Ueno Y, Kubota K (1976) DNA-attacking ability of carcinogen mycotoxins in recombination-deficient mutant cells of Bacillus subtilis. Cancer Res 36: 445–448Google Scholar
  24. Wojciechowski JP, Kaur P, Sabharwal PS (1981) Comparison of metabolic systems required to activate pro-mutagens/carcinogens in vitro for sister-chromatid exchange studies. Mutat Res 88: 89–97Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • M. Scheutwinkel
    • 1
  • W. v. d. Hude
    • 1
  • A. Basler
    • 1
  1. 1.Max von Pettenkofer-Institut des BundesgesundheitsamtesBerlin 33

Personalised recommendations